Amplify Therapeutics ApS: Financial statements 2023
CVR: 43803999
Source: annual report 2023, Danish Business Authority
23/01/2023 – 31/12/2023
Amplify Therapeutics ApS (CVR 43803999) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,558,702 and a net result of DKK -1,952,719. Equity in the 2023 report amounted to DKK -1,912,719. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,558,702
- Profit/Loss
- DKK -1,952,719
- Equity
- DKK -1,912,719
- Total Assets
- DKK 2,629,685
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of January 23, 2023, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Amplify Therapeutics ApS.
As of January 23, 2023, Anders Vadsholt has joined the board of directors of Amplify Therapeutics ApS.
As of January 23, 2023, Thomas Kirkegaard Jensen has joined the board of directors of Amplify Therapeutics ApS.
As of January 23, 2023, Anders Mørkeberg Hinsby has joined the board of directors of Amplify Therapeutics ApS.
As of January 23, 2023, Thomas Kirkegaard Jensen is registered as director of Amplify Therapeutics ApS.
As of January 23, 2023, Alpha Healthcare Investments ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 25%.
As of January 23, 2023, Dare to Dream ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 33%.
As of January 23, 2023, WoB Holding ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 25%.
Amplify Therapeutics ApS was founded on January 23, 2023.
About Amplify Therapeutics ApS
Amplify Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Thomas Kirkegaard Jensen. The board consists of Anders Mørkeberg Hinsby (chair), Anders Vadsholt and Thomas Kirkegaard Jensen. The company is owned by Alpha Healthcare Investments ApS, Dare to Dream ApS and WoB Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 925,944 and a net result of DKK -3,335,844 compared with DKK -7,194,854 the year before. Equity in the 2025 report amounted to DKK -12,443,417.